Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate Cancer
Randomized Phase IIb Preprostatectomy Study of Dietary Supplementation With Soy and Biomarkers of Prostate Cancer Risk and Progression
Sponsor: National Cancer Institute (NCI)
This PHASE2 trial investigates Prostate Cancer and is currently completed. National Cancer Institute (NCI) leads this study, which shows 8 recorded versions since 2003 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Sep 2018 — Jan 2021 [monthly]
Completed PHASE2
Phase: NA → PHASE2
-
Jun 2018 — Sep 2018 [monthly]
Completed NA
▶ Show 3 earlier versions
-
Dec 2017 — Jun 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jul 2017 — Dec 2017 [monthly]
Active Not Recruiting NA
Phase: PHASE2 → NA
-
Jan 2017 — Jul 2017 [monthly]
Active Not Recruiting PHASE2
First recorded
Oct 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
- Wake Forest University Health Sciences
For direct contact, visit the study record on ClinicalTrials.gov .